anabolic steroids and hepatic effects
Last reviewed 10/2022
Hepatic:
- various abnormal liver function tests (elevated alkaline phosphatase, aminotransferases,
conjugated bilirubin, and plasma proteins) have been associated with the use
of anabolic androgenic steroids (AAS)
- jaundice occasionally occurs as a result of hypersensitivity-type reaction
and is usually seen after 2-5 months of therapy
- cholestasis has been reported especially with the use of 17alpha-alkylated
agents
- in the majority of cases, the rise in transaminases is transient, with levels
normalizing within a few weeks of discontinuation of AAS
- peliosis hepatis and hepatocellular adenomas have been seen with the use of 17alpha-alkylated AAS
Reference: